These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25639763)

  • 1. Editorial comment.
    Odisho AY
    J Urol; 2015 May; 193(5):1613. PubMed ID: 25639763
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply by author.
    J Urol; 2015 May; 193(5):1613-4. PubMed ID: 25639762
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of county rurality and urologist density on urological cancer mortality in illinois.
    Frye TP; Sadowski DJ; Zahnd WE; Jenkins WD; Dynda DI; Mueller GS; Alanee SR; McVary KT
    J Urol; 2015 May; 193(5):1608-13. PubMed ID: 25498569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gender Issue.
    Hsieh JJ
    Clin Genitourin Cancer; 2020 Apr; 18(2):77. PubMed ID: 32273127
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer statistics digest. Mortality trend of prostate, breast, uterus, ovary, bladder and "kidney and other urinary tract" cancer in Japan by birth cohort.
    Kamo K; Sobue T
    Jpn J Clin Oncol; 2004 Sep; 34(9):561-3. PubMed ID: 15466832
    [No Abstract]   [Full Text] [Related]  

  • 6. [Incidence and mortality in malignant tumors of the urinary tract].
    Berndt H; Berndt R
    Z Arztl Fortbild (Jena); 1980 Dec; 74(24):1171-5. PubMed ID: 7222765
    [No Abstract]   [Full Text] [Related]  

  • 7. [Projected incidence and mortality from urologic cancer in France in 2010.].
    Rébillard X; Grosclaude P; Lebret T; Patard JJ; Pfister C; Richaud P; Rigaud J; Salomon L; Soulié M
    Prog Urol; 2010 Nov; 20 Suppl 4():S211-4. PubMed ID: 21129643
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of causes of death in the urologic department].
    Cieślińska K
    Pol Przegl Chir; 1969 Nov; 41(11):Suppl 11a:1590. PubMed ID: 5365641
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    Burger M
    Eur Urol; 2009 Mar; 55(3):657. PubMed ID: 18584941
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    Malats N; Real FX
    Eur Urol; 2009 Mar; 55(3):658. PubMed ID: 18584942
    [No Abstract]   [Full Text] [Related]  

  • 11. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.
    Mackey JR; Au HJ; Hugh J; Venner P
    J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment to characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy.
    Szarvas T
    Int J Urol; 2013 Sep; 20(9):872. PubMed ID: 23379970
    [No Abstract]   [Full Text] [Related]  

  • 13. LACTIC DEHYDROGENASE ISOZYMES IN URINE.
    RIGGINS RS; KISER WS
    Invest Urol; 1964 Jul; 2():30-7. PubMed ID: 14177627
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urology].
    Jichlinski P
    Rev Med Suisse; 2014 Jan; 10(412-413):127-9. PubMed ID: 24558917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with carcinomas of the testicle, prostate, and bladder.
    Stewart DJ
    Trans Assoc Life Insur Med Dir Am; 1987; 70():87-113. PubMed ID: 3037755
    [No Abstract]   [Full Text] [Related]  

  • 16. Mortality after urologic cancer surgery: impact of non-index case volume.
    Gilbert SM; Dunn RL; Miller DC; Daignault S; Ye Z; Hollenbeck BK
    Urology; 2008 May; 71(5):906-10. PubMed ID: 18372016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contentious controversies: a report from the 3rd World Congress on Controversies in Urology (February 25-28, 2010, Athens, Greece).
    Rabasseda X
    Drugs Today (Barc); 2010 Apr; 46(4):291-6. PubMed ID: 20502726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misleading interpretation of results from a small study.
    Altman DG
    Urology; 1994 Mar; 43(3):411-2. PubMed ID: 8135001
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiblastic chemotherapy in urology].
    Furnari S; Pavone-Macaluso S; Veroux G; Mattea E
    Minerva Urol; 1971; 23(2):87-9. PubMed ID: 5105988
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlaton of mortality for lower urinary tract cancer and medical resource factor].
    Watase H; Ishikawa A
    Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):625-9. PubMed ID: 16768142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.